Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.
about
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersHIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidaseSynergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytesPlatelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine AbuseHuman immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.HIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats.Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cellsCurcumin ameliorates hippocampal neuron damage induced by human immunodeficiency virus-1Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposureExcess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disordersMorphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?Long-acting slow effective release antiretroviral therapy.Methamphetamine potentiates HIV-1 gp120-mediated autophagy via Beclin-1 and Atg5/7 as a pro-survival response in astrocytes.HIV-associated neurological disorders: a guide to pharmacotherapy.Nervous system disorders across the life course in resource-limited settings.Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.Role of Autophagy in HIV Pathogenesis and Drug Abuse.HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens.
P2860
Q26777952-494C4223-9B14-4BC2-A1AC-C0EFB9313211Q28261913-2E3A1E8F-D9A8-4FF1-B7F7-08E8E4371AA3Q28484371-1F53667E-6D1D-47EC-8B3B-BB898DFF8E3AQ28548326-77DA46D3-F9DA-42E1-8B9D-D5F9F74FBC2FQ30497248-88C2C51D-EFCA-48D9-AB71-E9122D436E70Q33701989-3DDF498D-CBCB-47DB-ABCF-B89234F8CDA9Q33873538-5C9D03ED-86BC-415D-8ADD-223ED304E99BQ33937629-530B5C4D-C97E-44D7-BA2A-99EBFF66C1EEQ34281974-A5F7DBA9-E828-4A79-BB57-5AE1C00F329BQ34517239-E434AA22-64D7-4905-9633-1305D7F82338Q35606725-09B099C2-6AC4-4370-9E63-D32128149B13Q35770848-77282945-BBAC-401C-9A5C-5F524AAF6F3DQ36262152-93B356CA-5653-407F-9A02-7AEF317D7BAFQ37465911-4F9CF8BA-4D8D-4238-82EA-CC9E3AB2D90BQ37971469-FF857ED0-D5C8-4CD0-9C69-79F87273CB7DQ38637214-E37D4DA8-5EB1-48EC-8E61-4A5C95C45B7AQ38887687-32E758BA-220A-4AB5-9343-3940B7E2A46FQ38962319-E5079D3F-CF68-4A10-9904-8660173145F5Q40168892-C5AA817B-2FBD-4F5C-B732-DB3366533F56
P2860
Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Developing neuroprotective str ...... ed neurocognitive dysfunction.
@en
Developing neuroprotective str ...... ed neurocognitive dysfunction.
@nl
type
label
Developing neuroprotective str ...... ed neurocognitive dysfunction.
@en
Developing neuroprotective str ...... ed neurocognitive dysfunction.
@nl
prefLabel
Developing neuroprotective str ...... ed neurocognitive dysfunction.
@en
Developing neuroprotective str ...... ed neurocognitive dysfunction.
@nl
P2093
P2860
P356
P1433
P1476
Developing neuroprotective str ...... ed neurocognitive dysfunction.
@en
P2093
Avindra Nath
Jeffrey A Rumbaugh
Joseph Steiner
P2860
P304
P356
10.2217/17469600.2.3.271
P50
P577
2008-01-01T00:00:00Z